What your monthly recap looks like.

You moved from 5 mg to 7.5 mg in week 13 and held through the full month. Weight came down 4.2 lb against a goal pace of 3.5 — slightly ahead. Appetite scored 2/5 fewer days, side effects half what they were on the dose-up week, journal entries on day-after-shot showed the trough timing has shifted earlier (Tuesdays now, was Wednesdays at 5 mg).

This is the dose-finding window. Don't go up to 10 mg yet — there's another month of useful titration response still hiding in the 7.5 mg curve. Your fullness scores haven't plateaued.

Your trend slope steepened from −0.71 lb/wk on 5 mg to −0.96 lb/wk after the step-up — the kind of inflection that confirms the dose change is doing useful work.

SHOTS LOGGED

4 of 4Sundays

WEIGH-INS

22 of 2879% · skipped 3 weekends

JOURNAL ENTRIES

11avg 2.75/week

SYMPTOM LOGS

7all minor (nausea ≤2)

Week 13 (dose-up week) showed expected breakthrough nausea on Mon + Tue — both rated 2/5, both resolved by Wednesday evening. No reports in weeks 14–16. No gallbladder symptoms, no constipation flags, no early satiety beyond expected.

Cohort+ pulls the journal text alongside the symptom score so the prescriber sees context, not just numbers. Sample entry from your Wk 13 Tuesday: “Skipped breakfast, tried plain toast at 11, kept it down. Hydration helped.”

A1C

5.6 %down from 5.8 (Jan)

FASTING GLUCOSE

94 mg/dL+0 from last quarter

TOTAL CHOLESTEROL

198 mg/dL−12 from baseline

LDL

108 mg/dLwithin ±5

TRIGLYCERIDES

134 mg/dL−18 from baseline

RESTING HEART RATE

68 bpm−4 from baseline

The A1C drop is well within the expected tirzepatide range for your starting profile. Triglycerides moving in tandem with weight is the pattern you want — confirms metabolic response, not just scale movement.

The model gives an off-ramp readiness score based on dose-response stability, weight trajectory predictability, and lab markers. Yours is currently 38 / 100 — well below the 75 threshold we treat as a starting point for a prescriber-led taper conversation.

Realistic earliest off-ramp window if you stay on 7.5 mg: ~6 months from today. If you step up to 10 mg at month 5, that pushes to ~8 months from today (the model favors longer titration runs over rushed step-downs).

• Trough day timing. Your shift to Tuesday trough is normal at higher doses. If it slides further back (Monday), that's a signal the 7.5 mg dose is running out earlier than the weekly schedule — log it, we'll re-check next month.
• Resistance work. Cohort+ only sees what you log; if you started lifting this month and didn't add it to the activity tab, the model is undercounting your lean-mass preservation signal. Worth backfilling.